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Abstract
Objective: Systemic embolism is a serious complication after classical orthotopic transplantation, presumably originating from enlarged
left atrium. We speci®cally studied this problem after classical and modi®ed bicaval transplantation. Methods: Between December 1985 and
March 1999 we consecutively performed 72 classical and 106 modi®ed heart transplantation. Modi®cation included bicaval anastomosis and
recipient left atrium maximal reduction. Mean age was 47 years. All the patients received an antiplatelet therapy and were routinely followed.
When clinical signs of systemic embolism were present, a neurological evaluation and transesophageal echocardiography were done. Sixty
matched patients (30 of each group) had comparative transesophageal echocardiography study, at least 6 months after transplantation.
Results: Perioperative mortality was 17.4%. Mean follow-up was 6.8 2 1 /47 years. All patients were in sinus rhythm. Among 147 survivors,
11 patients who underwent classical transplantation had a systemic embolism, 1 month to 12 years after transplantation, 15.3%, (11/72). Two
limb ischemia and one mesenteric ischemia (needing surgery), seven strokes (one death, two permanent neurological de®cit). There was no
systemic embolism in the modi®ed technique group (P  0:013). Left atrial comparative transesophageal echocardiography study showed a
larger left atrial surface in classical transplantation. 33 ^ 4 cm2 versus 20 ^ 3 cm2 in a modi®ed technique, P  0:01. Spontaneous echo
contrast was present in 56% of classical technique group associated with atrial thrombosis in nine patients, there were no atrial thrombosis in
modi®ed technique group and spontaneous echocontrast was present in 0.5% (P  ,0:001). Conclusion: The occurrence of systemic
embolism, left atrial spontaneous echocontrast and thrombosis when using classical technique, and the absence of these complications
with the bicaval technique justi®ed the use of this method. Our experience with atrial thrombosis and spontaneous echocontrast rises the
question of anticoagulation in classical transplantation. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Systemic embolism is a serious complication or classical
orthotopic heart transplantation. The frequency of intracar-
diac thrombi after cardiac transplantation is probably under-
estimated. The incidence of reported cardiac embolism after
cardiac transplantation varies between 2 and 15% [1]. It is
accepted that most patients with intracardiac thrombi are
symptom free. However, several cases of systemic embo-
lism in patients undergoing a classical heart transplantation
(CHT) have been reported [2±6]. The reasons for formation
of intracardiac thrombi after classical heart transplantation
are presumably the enlarged left atria, (resulting for addition
of donor and recipient atria), the non-contractile portion of
recipient atrium and the asynchrony between the donor and
the recipient atria which encourages stasis [5,6].
The purpose of this study is to report our experience with
systemic embolism and to analyze the risk factors for atrial
thrombosis and systemic embolism after classical and modi-
®ed bicaval heart transplantation (BCHT).
2. Materials and Method
2.1. Patients
Between December 1985 and April 1999 we consecu-
tively performed 72 classical heart transplantation (CHT)
and subsequently 106 modi®ed BCHT. Mean age was
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46.6 ^ 19 years (0.8±71). The three staff members of the
surgical team carried out all the operations and have used
the same technique either in CHT or in BCHT. Indication
for transplantation was in 47 ischemic cardiomyopathy, 123
dilated cardiomyopathy, nine congenital cardiomyopathy,
and four valvular cardiomyopathy. Three patients had an
history of ischemic stroke 1 month, 1 and 10 years before
the cardiac transplantation.
All patients had before inscription in the waiting list a
complete check-up looking for contraindication, in particu-
lar peripheral vascular status, which was assessed by echo-
doppler and angiography when necessary.
When transplanted patients presented symptoms and
signs of systemic embolism, a transesophageal echocardio-
graphy (TEE), a vascular echodoppler and a brain computed
tomography (CT) scan were systematically done. Preopera-
tive data are detailed in Table 1.
2.2. Surgical technique in recipients
Modi®cations of the classical heart transplantation tech-
nique have consisted in: total right atria resection, reduction
of the left atria to a minimal cuff containing the four
pulmonary veins and everting suture between the recipient
pulmonary veins and the donor left atrium
2.3. Surgical technique in donors
Modi®cations of cardiac harvesting consisted in dissec-
tion and division of the superior vena cava just below the
Pyrogoff con¯uent.
When lungs were also harvested the heart was separated
from the lungs by division of the pulmonary artery 1 cm
below the bifurcation and reduction of the left atrium, in
order to keep a cuff of atrial tissue around the right and left
pulmonary veins.
2.4. Follow-up
All survivors (147 patients) were followed-up in our insti-
tution. A double immunosupression including Cya and ster-
oid was administrated in the ®rst two years following the
transplantation, and then steroids were stopped and substi-
tuted by Azathioprine.
All patients received an antiplatelet treatment (aspirin),
which was stopped if poorly tolerated. In patients who had
peripheral embolism an oral anticoagulant treatment was
administrated. Surveillance consisted in routine physical
examination, chest X-rays, surface EKG, yearly left and
right cardiac catheterization with coronary angiography
and myocardial biopsy. Transthoracic echocardiography
was usually utilized for evaluate cardiac function and
detect rejection. Transesophageal echocardiography was
done in 60 matched patients (30 CHT and 30 BCHT) 6
months after transplantation, and a comparative study was
undertaken. Subsequently TEE was performed routinely in
all patients.
2.5. Statistical methods
Univariate analysis (Chi-square or Student t-test) and
multivariate analysis (Cox test) were used.
To calculate the risk of event and the survival rate the
Kaplan±Meier method was utilized. A P value equal or less
than 0.05 was considered statistically signi®cant (Software
S.P.S.S.).
3. Results
Since the beginning of our experience in December 1985,
178 patients underwent a cardiac transplantation in our insti-
tution.
Seventy-two had a classical heart transplantation (group
I) and 106 a modi®ed total bicaval transplantation (group
II). There was no signi®cantly difference between the two
groups concerning sex ratio, pre-operative diagnosis, func-
tional NYHA class, and pulmonary vascular resistance.
Mean age was slightly greater in group II (48 years versus
44 years), and there were more patients over 60 years of age
in group II, 40.2 versus 19.8% in group I (P  0:02), due to
wider acceptance of older patients.
There was no complication due to the surgical technique.
The aortic cross-clamping time in the recipient (cardiac
excision and donor heart implantation) was longer in
group II (87.2 ^ 12 versus 65.4 ^ 15, P 0.001). The
donor ischemic time was also longer in group II
(87.2 ^ 53 versus 210 ^ 67 MN P  0:01). The increased
ischemic time was partially due to the surgical technique,
but also to harvesting carried out far from our center which
were more frequent in group II, 50 versus 24% in group I
(P  0:003). Perioperative mortality (30 days) was 17.4%
(32/178) in the whole group, without signi®cantly difference
between the two groups, 15.7% in group I and 18.4% in
group II (P  0:1).
The follow-up period was longer in group I, than in group
II 8.70 years (^4.50) versus 5.90 years (^3.28) P  0:001.
The actuarial survival rate was 76.9,70.59 and 66.19% at 3,6
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Table 1
Pre-operative data (n  178)
Age 46.6 ^ 19 years
(7 month±71 years)
Sex
Male 145
Female 33
Pre-operative diagnosis
Dilated 123
Ischemic 47
Congenital 9
Valvular 4
Atherosclerosis of the carotid arteries 28
Atrial ®brilation 5
Pre-operative strokea 3
a One permanent neurological de®cit.
and 9 years for the classical technique and 71.01, 69.47 and
67.43% for bicaval, without difference between the two
groups (P n.s.) (Fig. 1).
Among 82.5% perioperative (1 month) survivors 11
patients of group I (15.2%) had a systemic embolism 21
days to 12 years after operation. There were one mesenteric
ischemia, two lower limb ischemia, and eight strokes. Three
patients needed a surgical treatment: one a bowel resection
and two a surgical embolectomy of the lower limb. One
patient die due to a stroke, two had permanent neurological
de®cit (one hemiplegia, one monoplegia) and another had a
cerebral hemorrhage due to the anticoagulant treatment
given after a stroke. Left atrial thrombosis was shown at
TEE in 81.8% of these patients (9/11) The atrial thrombi
were located in four cases in the left atrial appendage, in two
cases on the atrio-atrial suture line and in the others three in
the recipient left atrial wall, close to the suture line. None of
the patient who underwent a BCHT had arterial embolism or
atrial thrombosis at TEE (P  0:013) (Fig. 2).
The vascular echo-doppler showed that 28 patients had
vascular lesions of the supraaortics trunks before the opera-
tion. Among these, 26 had diffuse atherosclerosis lesions
without evidence of stenosis and did not need any medical
or surgical treatment. Two patients had a stenotic lesion of
the carotid artery one of them needed a percutaneus dilata-
tion of the lesion with stenting. The other presented a mild
carotid stenosis and an antiplatelet treatment was admini-
strated. Eight patients who had diffuse atherosclerosis
lesions of supraortics trunks underwent a classical cardiac
transplantation and 3 of them had an episode of systemic
embolism (istroke two limb ischemia).
Among the three patients who had a stroke before the
transplantation, two underwent a cardiac transplantation
with the modi®ed technique and the other with the classical
technique. None of these patients presented any evidence of
systemic embolism along their follow-up. None of the
patients transplanted (group I and group II) presented a
right sided (right atrium, ventricle or pulmonary artery)
thrombosis or embolism.
Patient's characteristics are detailed in Table 2. All trans-
planted patients were in long term sinus rhythm, the post
operative surface EKG showed no major difference between
the two groups except a double atrial activity in patients
who had a CHT (14 versus 0) P  0:003.
The occurrence of acute rejection episodes was no signif-
icantly different in patients who had a peripheral embolism
than in patients free from embolism (1.8 ^ 2 versus
2.1 ^ 3) P  0:1. Chronic rejection de®ned by coronary
vascular lesions at yearly coronary angiograms were
presents in 19 patients. None of these patients bad any
evidence of systemic embolism.
Sixty matched patients (30 of each group) had a compara-
tive transthoracic and transeophageal echocardiography
study, at least 6 months after surgery, which showed a
major incidence of mild mitral incompetence in group, I
66 versus 33% in group II, (P  0:03), a major incidence
of left atria thrombosis, 12.5% (9/72) group I versus 0 in
group II, (P  0:02). Moreover a larger surface of the left
atria in CHT than in BCHT (33 ^ 4 cm2 versus 20 ^ 3 cm2)
P  0:01, and an increased incidence of spontaneous echo-
contrast in group I than in group II (56 ^ 0.5%) P  0:001
were founded. Nine patients had a concomitant lung
harvesting in donors, four of group I and ®ve of group II.
The measurement of the left atrium surface reveled also in
these cases signi®cantly larger atria in patients operated
with CHT 29 ^ 5 cm2 versus 21 ^ 21 cm2 in the BCHT
(P  0:03).
The univariate and multivariate analysis of risk factors:
age peripheral vascular status, the absence of antiplatelet
treatment, the impaired left diastolic function, (de®ned as
an end diastolic left ventricular pressure greater than 17
mmHg at cardiac catheterization), the decreased left systolic
function, (de®ned as an ejection fraction inferior to 50% at
echocardiography and or at cardiac angiocardiogram), atrial
®brillation or sinus rhythm before surgery, and surgical
technique, recognized the surgical technique as the only
factor favoring peripheral embolism. In contrast the altered
diastolic function and the absence of antiplatelet treatment
were risk factor for death (Table 3).
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Fig. 1. Actuarial survival curve after CHT and BCHT Kaplan±Meier
method.
Fig. 2. Univariate analysis (Kaplan±Meier). Actuarial risk of systemic
embolism after cardiac transplantation with CHT and BCHT.
4. Discussion
Systemic embolism is a serious complication after classi-
cal cardiac transplantation The incidence of left atrial
thrombi in patients who underwent a CHT is unknown
since the majority of these patients are asymptomatic [3,4]
and intracardiac thrombi are only detected by TEE or thor-
acic CT scan [1±3,6±8].
The physiopathology of intracardiac thrombi formation in
patients undergoing CHT is not completely understood,
although several factors may be involved:
² Alteration in hemostatic mechanism has been shown to
exist. An increase in platelet aggregation has been
observed which is due to the inhibited endothelial pros-
tacylcine synthesis mediated by cyclosporine. This
abnormality in platelet aggregation is resistant to conven-
tional antiplatelet treatment [9]. In our series of patients,
there was no difference in the incidence of atrial throm-
bosis and peripheral embolism between patients with or
without antiplatelet treatment. On the other hand rejec-
tion deplete the endothelial thrombomodulin and the
antithrombin III which results in an increased thrombo-
genic incidence [10]. In our experience there were no
difference in rejection incidence between the group of
patients having peripheral embolism and the free of
systemic embolism group.
² The resulting enlarged left atrium after CHT favors blood
stasis and thrombi formation. The presence of sponta-
neous echocontrast has been observed in a high percen-
tage of patients undergoing a CHT [1,2,5±8,11,12].
² In our series all patients who had an episode of peripheral
embolism had underwent a classical cardiac transplanta-
tion, and in this group of patients an enlarged left atrium
and an increased incidence of spontaneous echocontast
(SEC) were observed by TEE when compared to BCHT
group. Others technical factors were found to predispose
a patient to forming thrombi, because the TEE showed
thrombotic formation along the atrial suture line [2,11].
This was also reported after lung transplantation on the
cuff of left atrium [12,13]. In all patients undergoing a
CHT the suture line was visualized and in two of then an
intracardiac thrombus was observed at TEE. None of
patients who underwent a BCHT had an apparent suture
line at TEE. This is probably due to the everting suture
technique used in the anastomosis between the recipients
pulmonary veins and the donor left atrium. The impaired
diastolic and systolic function may be linked to the
formation of intracardiac thrombi [3,7,14]. In our series
two patients among the 11 having a systemic embolism
had an impaired diastolic function. The systolic function
was normal in all patients of this group.
² The asynchronous contraction of the recipient and donor
atrial components as well as the presence of arrhythmia
induce blood stasis and may result in an increasing
thrombogenic propensity [3,7,11,15,16]. Three patients
who had a stroke in our series presented a double atrial
activity and this was observed in 46.6% of patients
undergoing a CHT. Atrial ®brillation in the recipient
atrial component has been reported as favoring atrial
thrombosis [1,15]. None of the patients having an atrial
thrombosis and/or a systemic embolism had a ®brillation
of the recipient component of the atria in our experience.
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Table 2
Patients having a systemic embolism, after cardiac transplantation (n  11)
Patients No. Age (years) Clinical signs Time to embolism Surgical techniquea Evolution
1 30 Limb ischemia 21 days CHT Surgical embolectomy
2 48.5 Stroke 28 days CHT No sequel
3 51.8 Stroke 3 months CHT Permanent hemiplegia
4 38.9 Mesenteric ischemia 3 years CHT Surgical bowel resect ion
5 60.08 Stroke 5 years CHT No sequel
6 41.5 Stroke 6 years CHT Cerebral hemorrageb
7 42.0 Stroke 7 years CHT Monoplegia
8 55.8 Stroke 8 years CHT Death
9 69.3 Stroke 9 years CHT No sequel
10 54.2 Limb ischemia 10 years CHT Surgical embolectomy
11 56 Stroke 12 years CHT No sequel
a None of patients undergoing BCHT had a systemic embolism.
b Cerebral haematoma due to the anticoagulant treatment.
Table 3
Multivariate analysis (Cox test)
Variant Free of embolism Embolism Pa
Age (years) 46.3 ^ 17 48.4 ^ 11 1
Carotid disease 25 3 0.9
No anti platelets treatment 35 2 0.3
Impaired left diastolic function 32 2 1
Decreased left systolic function 12 0 1
Atrial ®brillation before surgery 5 0 1
Surgical technique
CHT 61 11 0.04
BCHT 106 0
a P  ,0:05 was signi®cant.
Moreover we don't have observed arrhythmia among our
cohort of patients.
² The peripheral vascular satus of patients undergoing heart
transplantation may also predispose to arterial thrombosis
or embolism. In our cohort of patients eight among the
CHT group presented a diffuse atherosclerosis of the
supraaortics trunks, three of them had an episode of arter-
ial embolism and demonstration of a left atrial thrombi,
which suggest that the arterial embolism was probably due
to the left atrial thrombus. In the CHT group only two
patients among eleven presenting an arterial embolism
were free of left atrial thrombosis at TEE study and did
not presented any evidence of peripheral vascular disease
at the echodoppler study. Another possible important
factor in thrombo-embolic events is the duration of the
follow-up period. Incidence of thrombo-embolic compli-
cations increases with time [17]. In our series 54.5%
(6/11) of episodes of arterial embolism occurred in the
early or mid term follow up and 45.5% (5/11) in the late
follow-up period, and this represents a limitation in our
study since the two compared series are consecutive and
the mean follow-up for the bicaval group is shorter than in
classical technique group 5.90 years versus 8.70 years,
respectively.
5. Conclusion
Atrial thrombosis and systemic embolism after heart
transplantation are probably underestimated, and more
studies are necessary to shed light on its actual incidence.
All the conditions favoring blood stasis and left atrial throm-
bosis are found after CHT, in contrast BCHT seems to
decrease considerably this problem, without increasing the
perioperative mortality and morbidity and this only fact
justi®es the use of this technique. Our experience of left
atrial thrombosis, and frequent left atrial echocontrast
rises the question of the anticoagulation in patients who
had undergone a CHT.
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Appendix A. Conference discussion
Dr P. Totaro (Brescia, Italy): I did a similar study when I was working in
Northern General Hospital in Shef®eld. We found a similar incidence of
atrial thrombosis in patients without any sign of peripheral embolism. We
treated them with oral anticoagulation and they recovered very well and
their thrombosis disappeared.
So my question is, does your incidence regard overall population or only
the patients with clinical signs of peripheral embolism?
And the second one is, how did you treat the patient with the left atrial
thrombosis?
Dr Riberi: For all patients with left arterial thrombosis with an antic-
oagulant treatment by an oral ± this is your question?
Dr Totaro: Yes. Did you give just oral anticoagulant, or did you give
intravenous heparin for some time?
Dr Riberi: In the beginning we induced the treatment with heparin in
vein and then we go on oral anticoagulant treatment with it.
I'm sorry, I didn't understand the ®rst question.
Dr Totaro: Does your incidence of left atrial thrombosis regard all the
patients with a heart transplant or only the patients with clinical signs of
peripheral embolism?
Dr Riberi: Forty percent of patients with classical heart transplantation in
our population have a left atrial thrombosis.
Dr Totaro: I mean we found 14% of incidence of left atrial thrombosis
just as a routine surveillance of echocardiographic in asymptomatic
patients.
Dr Riberi: Yes.
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Dr Totaro: Is yours the same?
Dr Riberi: Yes.
Dr C. Yankah (Berlin, Germany): You may have a peripheral thrombosis
or thromboembolic episodes without having atrial thrombosis. These
patients sometimes have preoperatively heparin therapy. And we have
some experience in some certain patients who developed heparin-induced
thrombocytopenia and also caused some peripheral thromboembolitic
episodes, even as well as also the cerebral. Have you observed or diagnosed
heparin-induced thrombocytopenia (HIT type II). Perhaps these two
patients were HIT patients.
Dr Riberi: No, we have never found these kinds of complications with
heparin.
Dr A. Haverich (Hannover, Germany): The bicaval technique in and by
itself does not in¯uence thromboembolism from the left atrium. Therefore
the title of the presentation is somewhat misleading.
On the other hand, if you also change the technique of suturing the left
atrium, making it much smaller, that has de®nitely an in¯uence. Our cardi-
ologists always tell us to occlude the left atrial appendage on the donor
heart. Did you change that as well when changing your technique between
the ®rst and the second group of your study?
Dr Riberi: We sutured the left appendage ± this is your question?
Dr Haverich: Yes. And did you occlude the left atrial appendage?
Dr Riberi: Yes, always.
Dr Haverich: With both techniques?
Dr Riberi: No. We began with the bicaval techniques to do it.
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